Skip to main content

Patient stratification for treatment decisions and tumour-normal pair or liquid biopsy specimen profiling for patient-unique therapies

NGS-based molecular profiling with clinical-relevant turnaround times for precision oncology brings treatment decisions & personalized cancer treatment manufacturing within reach. For clinical profiling, a clinical relevant turnaround time is key. We have dedicated solutions for low-input and FFPE-tissues.


Combination of genetic and transcriptomic characterization of paired tumour-normal specimens or blood allows for a quick prediction and selection of neoantigens for personal cancer vaccine development and adoptive cell therapies. In addition, we offer solutions to verify your viral vector-, CAR-T or TCR-T libraries.

Patient stratification for treatment decisions with dedicated biomarkers, comprehensive cancer panels and stratification at genetic (including WGS), transcriptomic, and epigenetic level are at your disposal.

oncology Clinical profiling
stefanie 350x350 Clinical profiling

How can I help you?

Connect with Head of Oncology

Our solutions

Cancer Panels
Genetics and
Clinical Services

Let's get the conversation started for your next NGS project

Please either fill in below or email us directly at
and we will get in touch with you to discuss your requirements